These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Prognosis prediction for childhood acute lymphoblastic leukemia--review]. Liu Y Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):202-6. PubMed ID: 17490555 [TBL] [Abstract][Full Text] [Related]
6. Detection of minimal residual disease in pediatric acute lymphoblastic leukemia. Gaipa G; Basso G; Biondi A; Campana D Cytometry B Clin Cytom; 2013; 84(6):359-69. PubMed ID: 23757107 [TBL] [Abstract][Full Text] [Related]
7. The clinical relevance of detection of minimal residual disease in childhood acute lymphoblastic leukaemia. Moppett J; Burke GA; Steward CG; Oakhill A; Goulden NJ J Clin Pathol; 2003 Apr; 56(4):249-53. PubMed ID: 12663634 [TBL] [Abstract][Full Text] [Related]
9. Advances in the genetics of acute lymphoblastic leukemia in adults and the potential clinical implications. Horowitz NA; Akasha D; Rowe JM Expert Rev Hematol; 2018 Oct; 11(10):781-791. PubMed ID: 30092672 [TBL] [Abstract][Full Text] [Related]
10. Detection of residual disease in childhood acute lymphoblastic leukemia. Machida U; Kami M; Hirai H N Engl J Med; 1999 Jan; 340(2):153-4. PubMed ID: 9917221 [No Abstract] [Full Text] [Related]
15. [Role of biology in the characterization, understanding and treatment of acute lymphoblastic leukemia in children]. Baruchel A Arch Pediatr; 2003 May; 10 Suppl 1():102s-105s. PubMed ID: 14509760 [No Abstract] [Full Text] [Related]
16. Long-term results of treatment of childhood acute lymphoblastic leukemia in the Czech Republic. Stary J; Jabali Y; Trka J; Hrusak O; Gajdos P; Hrstkova H; Sterba J; Blazek B; Hak J; Prochazkova D; Cerna Z; Smisek P; Sedlacek P; Vavra V; Mihal V; Hrodek O; Leukemia; 2010 Feb; 24(2):425-8. PubMed ID: 20016535 [No Abstract] [Full Text] [Related]
17. Long-term results of the Israeli National Studies in childhood acute lymphoblastic leukemia: INS 84, 89 and 98. Stark B; Nirel R; Avrahami G; Abramov A; Attias D; Ballin A; Bielorai B; Burstein Y; Gavriel H; Elhasid R; Kapelushnik J; Sthoeger D; Toren A; Wientraub M; Yaniv I; Izraeli S Leukemia; 2010 Feb; 24(2):419-24. PubMed ID: 20016534 [No Abstract] [Full Text] [Related]
18. Molecular diagnostics in the treatment of childhood acute lymphoblastic leukemia. Rubnitz JE J Biol Regul Homeost Agents; 2000; 14(3):182-6. PubMed ID: 11037050 [TBL] [Abstract][Full Text] [Related]
19. Pediatric acute lymphoblastic leukemia: there is no TEL-ing what wonders lie ahead. Sandoval C Leuk Res; 2010 Apr; 34(4):418-9. PubMed ID: 19892401 [No Abstract] [Full Text] [Related]
20. Predictive factors of relapse and survival in childhood acute myeloid leukemia: role of minimal residual disease. Rizzari C; Cazzaniga G; Coliva T; De Angelis C; Conter V Expert Rev Anticancer Ther; 2011 Sep; 11(9):1391-401. PubMed ID: 21929313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]